Popular:
Optimize growth hormone for recovery and lean mass
Cycle Length
8 to 12 weeks
Goal
Strength and recovery
Experience Level
Beginner friendly
Shipping
Free with subscription
The Performance Protocol is designed around growth hormone optimization. The CJC-1295/Ipamorelin Blend provides a sustained, pulsatile release of growth hormone by combining a GHRH analog with a selective ghrelin receptor agonist. This means elevated GH levels without the cortisol or prolactin spikes associated with other secretagogues. The standalone Ipamorelin vial allows for additional dosing flexibility throughout the cycle. Research has linked optimized growth hormone levels to improved recovery between training sessions, better sleep quality, and support for lean muscle tissue. This protocol is a strong fit for researchers focused on strength, endurance, and long-term performance.
CJC-1295 is a GHRH (growth hormone releasing hormone) analog that extends the half-life of endogenous GH pulses. Combined with Ipamorelin, a selective ghrelin receptor agonist, it produces sustained GH elevation without the cortisol or prolactin spikes seen with other secretagogues.
The standalone Ipamorelin vial provides additional dosing flexibility. Ipamorelin is one of the cleanest GH-releasing peptides available, with a strong safety profile in research settings.
Optimized growth hormone levels have been linked in published research to faster recovery, improved sleep architecture, better body composition, and support for connective tissue health.
5mg / 5mg · ≥98% purity
Growth hormone support for recovery and body composition
Included Supplies
Subscribe to receive your protocol automatically each month. You can pause, skip, or cancel anytime from your account. Every product in this protocol ships with a published Certificate of Analysis from an independent US lab.
8-12 weeks cycle · 2 peptides included
Subscribe & Save 15%
$200 one-time
Free shipping on all subscriptions
Cancel or pause anytime
Full CoA published for every batch
Explore our other goal-based stacks.
All protocols represent common research configurations documented in published scientific literature. They do not constitute medical treatment plans, therapeutic recommendations, or dosing instructions for human use. All products are for in-vitro laboratory research only.